参考文献/References:
[1] Yao Y, Shang MS, Dong JZ, et al. Homocysteine in non-valvular atrial fibrillation: Role and clinical implications[J]. Clin Chim Acta ,2017,475(9):85-90.
[2] Kirchhof P, Benussi S, Kotecha D, et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J].Eur Heart J,2016,37(38):2893-2962.
[3]李旭楠,杨晓蕾,夏云龙.活性氧在心房颤动中的作用机制[J].心血管病学进展,2019,40(2):181-184.
[4] Snezhitsky VA, Yatskevich ES, Doroshenko EM, et al.Homocysteine as a prognostic marker of atrial remodeling and clinical picture in patients with paroxysmal and persistent forms of atrial fibrillation[J].Klin Med (Mosk),2016,94(1):16-22.
[5] Zaric BL, Obradovic M, Bajic V, et al.Homocysteine and Hyperhomocysteinaemia[J]. Curr Med Chem,2019,26(16):2948-2961.
[6] Kim J, Kim H, Roh H, et al.Causes of hyperhomocysteinemia and its pathological significance[J].Arch Pharm Res,2018,4 1(4):372-383.
[7] Djuric D, Jakovljevic V, Zivkovic V, et al.Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems[J]. Can J Physiol Pharmacol,2018,96(10):991-1003.
[8] McCully KS.Homocysteine and the pathogenesis of atherosclerosis[J].Expert Rev Clin Pharmacol,2015,8(2):211-219.
[9] Koller A, Szenasi A, Dornyei G, et al.Coronary microvascular and cardiac dysfunction due to homocysteine pathometabolism; a complex therapeutic design[J].Curr Pharm Des,2018,24(25):2911-2920.
[10] Shimano M, Inden Y, Tsuji Y, et al.Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation[J].Europace, 2008,10(8): 961-966.
[11] Shi D, Meng Q, Zhou X, et al.Factors influencing the relationship between atrial fibrillation and artery stiffness in elderly Chinese patients with hypertension[J].Aging Clin Exp Res,2016,28(4):653-658.
[12] Kubota Y, Alonso A, Heckbert SR, et al.Homocysteine and incident atrial fibrillation:the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis[J].Heart Lung Circ,2019,28(4):615-622.
[13] 林育辉,戴文军,何晓青.慢性心力衰竭合并心房颤动患者心型脂肪酸结合蛋白、超敏C反应蛋白及同型半胱氨酸水平的变化[J].实用医学杂志,2018,34(8): 1327-1329.
[14] Yao Y, Shang MS, Gao LJ, et al.Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score[J]. Europace,2017,20(7):1093-1098.
[15] Ay H, Arsava EM, Tokg?zoglu SL, et al.Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation[J]. Stroke,2003,34(4):909-912.
[16] Naji F, Suran D, Kanic V, et al.High homocysteine levels predict the recurrence of atrial fibrillation after successful electrical cardioversion[J]. Int Heart J,2010,51(1): 30-33.
[17] Yao Y, Yao W, Bai R, et al. Plasma homocysteine levels predict early recurrence after catheter ablation of persistent atrial fibrillation[J].Europace,2017,19(1):66-71.
[18] Nasso G, Bonifazi R, Romano V, et al.Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation[J]. J Thorac Cardiovasc Surg,2013,146(4):848-853.
[19] Zou Z, Lu Y, Dong M, et al.Effect of homocysteine on voltage-gated sodium channel currents in primary cultured rat caudate nucleus neurons and its modulation by 2-Arachidonylglycerol[J]. J Mol Neurosci,2015,57(4):477-485.
[20] Law P, Kharche S, Stott J, et al.Effects of elevated Homocysteine hormone on electrical activity in the human atrium:a simulation study[J]. Conf Proc IEEE Eng Med Biol Soc,2009 ,2009:3936-3939.
[21] 韩璐,董泉彬,韦怡春,等.同型半胱氨酸短期干预对大鼠心房肌细胞钙超载的作用及机制研究[J].中华心血管病杂志,2018,46(2):143-151.
[22] Zhang Z, Wei C, Zhou Y, et al.Homocysteine induces apoptosis of human umbilical vein endothelial cells via mitochondrial dysfunction and endoplasmic reticulum stress[J]. Oxid Med Cell Longev,2017,2017(1):5736506.
[23] da Cunha AA, Ferreira AG, Loureiro SO, et al.Chronic hyperhomocysteinemia increases inflammatory markers in hippocampus and serum of rats[J].Neurochem Res,2012,37(8):1660-1669.
[24] Zanin RF, Bergamin LS, Morrone FB, et al.Pathological concentrations of homocysteine increases IL-1β production in macrophages in a P2X7, NF-?B, and erk-dependent manner[J].Purinergic Signal,2015,11(4):463-470.
[25] Iwasaki YK, Nishida K, Kato T, et al. Atrial fibrillation pathophysiology: implications for management[J]. Circulation, 2011, 124(20):2264-2274.
[26] Jeremic J, Nikolic Turnic T, Zivkovic V, et al.Vitamin B complex mitigates cardiac dysfunction in high-methionine diet-induced hyperhomocysteinemia[J].Clin Exp Pharmacol Physiol,2018,45(7):683-693.
[27] Maldonado C, So ni CV, Todnem ND, et al. Hyperhomocysteinemia and sudden cardiac death: potential arrhythmogenic mechanisms[J]. Curr Vasc Pharmacol, 2010, 8(1):64-74.
[28] Pushpakumar S, Kundu S, Sen U. Hydrogen sulfide protects hyperhomocysteinemia-induced renal damage by modulation of caveolin and eNOS interaction[J].Sci Rep,2019,9(1):2223.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(9):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(9):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(9):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(9):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(9):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(9):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]